Predictors of Global Non-Motor Symptoms Burden Progression in Parkinson's Disease. Results from the COPPADIS Cohort at 2-Year Follow-Up

Background and Objective: Non-motor symptoms (NMS) progress in different ways between Parkinson's disease (PD) patients. The aim of the present study was to (1) analyze the change in global NMS burden in a PD cohort after a 2-year follow-up, (2) to compare the changes with a control group, and...

Descripción completa

Detalles Bibliográficos
Autores: Diego, SG, Teresa, DD, Cores, C, Canfield, H, Paz Gonzalez, JM, Miro, CM, Aymerich, LV, Suarez, E, Jesus, S, Aguilar, M, Pastor, P, Planellas, L, Cosgaya, M, Caldentey, JG, Caballol, N, Legarda, I, Hernandez-Vara, J, Cabo, I, Manzanares, LL, Aramburu, IG, Avila Rivera, MA, Catalan, MJ, Nogueira, V, Puente, V, Dotor, J, Borrue, C, Solano, B, Alvarez Sauco, M, Vela, L, Escalante, S, Cubo, E, Carrillo, F, Martinez Castrillo, JC, Alonso, PS, Alonso, G, Ariztegui, NL, Gaston, I, Kulisevsky, J, Blazquez, M, Seijo, M, Ruiz Martinez, J, Valero, C, Kurtis, M, de Fabregues, O, Ardura, J, Alonso, R, Ordas, C, Diaz, LML, McAfee, D, Martinez-Martin, P, Mir, P, COPPADIS Study Group
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2021
País:España
Institución:Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)
Repositorio:r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
OAI Identifier:oai:iibsantpau.fundanetsuite.com:p4567
Acceso en línea:https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=4567
https://ddd.uab.cat/record/271912
Access Level:acceso abierto
Palabra clave:mood
non-motor symptoms
Parkinson's disease
progression
quality of life
id ES_fccc87e3cd7db6a8e558d50238bc014b
oai_identifier_str oai:iibsantpau.fundanetsuite.com:p4567
network_acronym_str ES
network_name_str España
repository_id_str
spelling Predictors of Global Non-Motor Symptoms Burden Progression in Parkinson's Disease. Results from the COPPADIS Cohort at 2-Year Follow-UpDiego, SGTeresa, DDCores, CCanfield, HPaz Gonzalez, JMMiro, CMAymerich, LVSuarez, EJesus, SAguilar, MPastor, PPlanellas, LCosgaya, MCaldentey, JGCaballol, NLegarda, IHernandez-Vara, JCabo, IManzanares, LLAramburu, IGAvila Rivera, MACatalan, MJNogueira, VPuente, VDotor, JBorrue, CSolano, BAlvarez Sauco, MVela, LEscalante, SCubo, ECarrillo, FMartinez Castrillo, JCAlonso, PSAlonso, GAriztegui, NLGaston, IKulisevsky, JBlazquez, MSeijo, MRuiz Martinez, JValero, CKurtis, Mde Fabregues, OArdura, JAlonso, ROrdas, CDiaz, LMLMcAfee, DMartinez-Martin, PMir, PCOPPADIS Study Groupmoodnon-motor symptomsParkinson's diseaseprogressionquality of lifeBackground and Objective: Non-motor symptoms (NMS) progress in different ways between Parkinson's disease (PD) patients. The aim of the present study was to (1) analyze the change in global NMS burden in a PD cohort after a 2-year follow-up, (2) to compare the changes with a control group, and (3) to identify predictors of global NMS burden progression in the PD group. Material and Methods: PD patients and controls, recruited from 35 centers of Spain from the COPPADIS cohort from January 2016 to November 2017, were followed-up with after 2 years. The Non-Motor Symptoms Scale (NMSS) was administered at baseline (V0) and at 24 months +/- 1 month (V2). Linear regression models were used for determining predictive factors of global NMS burden progression (NMSS total score change from V0 to V2 as dependent variable). Results: After the 2-year follow-up, the mean NMS burden (NMSS total score) significantly increased in PD patients by 18.8% (from 45.08 +/- 37.62 to 53.55 +/- 42.28; p < 0.0001; N = 501; 60.2% males, mean age 62.59 +/- 8.91) compared to no change observed in controls (from 14.74 +/- 18.72 to 14.65 +/- 21.82; p = 0.428; N = 122; 49.5% males, mean age 60.99 +/- 8.32) (p < 0.0001). NMSS total score at baseline (beta = -0.52), change from V0 to V2 in PDSS (Parkinson's Disease Sleep Scale) (beta = -0.34), and change from V0 to V2 in NPI (Neuropsychiatric Inventory) (beta = 0.25) provided the highest contributions to the model (adjusted R-squared 0.41; Durbin-Watson test = 1.865). Conclusions: Global NMS burden demonstrates short-term progression in PD patients but not in controls and identifies worsening sleep problems and neuropsychiatric symptoms as significant independent predictors of this NMS progression.MDPI2021info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttps://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=4567https://ddd.uab.cat/record/271912Journal of Personalized MedicineISSN: 20754426reponame:r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pauinstname:Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)Inglésinfo:eu-repo/semantics/openAccessoai:iibsantpau.fundanetsuite.com:p45672026-06-14T12:41:47Z
dc.title.none.fl_str_mv Predictors of Global Non-Motor Symptoms Burden Progression in Parkinson's Disease. Results from the COPPADIS Cohort at 2-Year Follow-Up
title Predictors of Global Non-Motor Symptoms Burden Progression in Parkinson's Disease. Results from the COPPADIS Cohort at 2-Year Follow-Up
spellingShingle Predictors of Global Non-Motor Symptoms Burden Progression in Parkinson's Disease. Results from the COPPADIS Cohort at 2-Year Follow-Up
Diego, SG
mood
non-motor symptoms
Parkinson's disease
progression
quality of life
title_short Predictors of Global Non-Motor Symptoms Burden Progression in Parkinson's Disease. Results from the COPPADIS Cohort at 2-Year Follow-Up
title_full Predictors of Global Non-Motor Symptoms Burden Progression in Parkinson's Disease. Results from the COPPADIS Cohort at 2-Year Follow-Up
title_fullStr Predictors of Global Non-Motor Symptoms Burden Progression in Parkinson's Disease. Results from the COPPADIS Cohort at 2-Year Follow-Up
title_full_unstemmed Predictors of Global Non-Motor Symptoms Burden Progression in Parkinson's Disease. Results from the COPPADIS Cohort at 2-Year Follow-Up
title_sort Predictors of Global Non-Motor Symptoms Burden Progression in Parkinson's Disease. Results from the COPPADIS Cohort at 2-Year Follow-Up
dc.creator.none.fl_str_mv Diego, SG
Teresa, DD
Cores, C
Canfield, H
Paz Gonzalez, JM
Miro, CM
Aymerich, LV
Suarez, E
Jesus, S
Aguilar, M
Pastor, P
Planellas, L
Cosgaya, M
Caldentey, JG
Caballol, N
Legarda, I
Hernandez-Vara, J
Cabo, I
Manzanares, LL
Aramburu, IG
Avila Rivera, MA
Catalan, MJ
Nogueira, V
Puente, V
Dotor, J
Borrue, C
Solano, B
Alvarez Sauco, M
Vela, L
Escalante, S
Cubo, E
Carrillo, F
Martinez Castrillo, JC
Alonso, PS
Alonso, G
Ariztegui, NL
Gaston, I
Kulisevsky, J
Blazquez, M
Seijo, M
Ruiz Martinez, J
Valero, C
Kurtis, M
de Fabregues, O
Ardura, J
Alonso, R
Ordas, C
Diaz, LML
McAfee, D
Martinez-Martin, P
Mir, P
COPPADIS Study Group
author Diego, SG
author_facet Diego, SG
Teresa, DD
Cores, C
Canfield, H
Paz Gonzalez, JM
Miro, CM
Aymerich, LV
Suarez, E
Jesus, S
Aguilar, M
Pastor, P
Planellas, L
Cosgaya, M
Caldentey, JG
Caballol, N
Legarda, I
Hernandez-Vara, J
Cabo, I
Manzanares, LL
Aramburu, IG
Avila Rivera, MA
Catalan, MJ
Nogueira, V
Puente, V
Dotor, J
Borrue, C
Solano, B
Alvarez Sauco, M
Vela, L
Escalante, S
Cubo, E
Carrillo, F
Martinez Castrillo, JC
Alonso, PS
Alonso, G
Ariztegui, NL
Gaston, I
Kulisevsky, J
Blazquez, M
Seijo, M
Ruiz Martinez, J
Valero, C
Kurtis, M
de Fabregues, O
Ardura, J
Alonso, R
Ordas, C
Diaz, LML
McAfee, D
Martinez-Martin, P
Mir, P
COPPADIS Study Group
author_role author
author2 Teresa, DD
Cores, C
Canfield, H
Paz Gonzalez, JM
Miro, CM
Aymerich, LV
Suarez, E
Jesus, S
Aguilar, M
Pastor, P
Planellas, L
Cosgaya, M
Caldentey, JG
Caballol, N
Legarda, I
Hernandez-Vara, J
Cabo, I
Manzanares, LL
Aramburu, IG
Avila Rivera, MA
Catalan, MJ
Nogueira, V
Puente, V
Dotor, J
Borrue, C
Solano, B
Alvarez Sauco, M
Vela, L
Escalante, S
Cubo, E
Carrillo, F
Martinez Castrillo, JC
Alonso, PS
Alonso, G
Ariztegui, NL
Gaston, I
Kulisevsky, J
Blazquez, M
Seijo, M
Ruiz Martinez, J
Valero, C
Kurtis, M
de Fabregues, O
Ardura, J
Alonso, R
Ordas, C
Diaz, LML
McAfee, D
Martinez-Martin, P
Mir, P
COPPADIS Study Group
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv mood
non-motor symptoms
Parkinson's disease
progression
quality of life
topic mood
non-motor symptoms
Parkinson's disease
progression
quality of life
description Background and Objective: Non-motor symptoms (NMS) progress in different ways between Parkinson's disease (PD) patients. The aim of the present study was to (1) analyze the change in global NMS burden in a PD cohort after a 2-year follow-up, (2) to compare the changes with a control group, and (3) to identify predictors of global NMS burden progression in the PD group. Material and Methods: PD patients and controls, recruited from 35 centers of Spain from the COPPADIS cohort from January 2016 to November 2017, were followed-up with after 2 years. The Non-Motor Symptoms Scale (NMSS) was administered at baseline (V0) and at 24 months +/- 1 month (V2). Linear regression models were used for determining predictive factors of global NMS burden progression (NMSS total score change from V0 to V2 as dependent variable). Results: After the 2-year follow-up, the mean NMS burden (NMSS total score) significantly increased in PD patients by 18.8% (from 45.08 +/- 37.62 to 53.55 +/- 42.28; p < 0.0001; N = 501; 60.2% males, mean age 62.59 +/- 8.91) compared to no change observed in controls (from 14.74 +/- 18.72 to 14.65 +/- 21.82; p = 0.428; N = 122; 49.5% males, mean age 60.99 +/- 8.32) (p < 0.0001). NMSS total score at baseline (beta = -0.52), change from V0 to V2 in PDSS (Parkinson's Disease Sleep Scale) (beta = -0.34), and change from V0 to V2 in NPI (Neuropsychiatric Inventory) (beta = 0.25) provided the highest contributions to the model (adjusted R-squared 0.41; Durbin-Watson test = 1.865). Conclusions: Global NMS burden demonstrates short-term progression in PD patients but not in controls and identifies worsening sleep problems and neuropsychiatric symptoms as significant independent predictors of this NMS progression.
publishDate 2021
dc.date.none.fl_str_mv 2021
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=4567
https://ddd.uab.cat/record/271912
url https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=4567
https://ddd.uab.cat/record/271912
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv MDPI
publisher.none.fl_str_mv MDPI
dc.source.none.fl_str_mv Journal of Personalized Medicine
ISSN: 20754426
reponame:r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname:Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)
instname_str Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)
reponame_str r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
collection r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869425482120822784
score 15,811543